Assignee
TREFOIL THERAPEUTICS INC
US·2 granted patents·4 pending applications·2 citations·filing 2014–2024
Top patents by PatentIndex Score
6 records- 0175US11103553B2Modified fibroblast growth factors for the treatment of ocular disordersTREFOIL THERAPEUTICS INC·Filed 2014·Granted Aug 31, 2021·2 cites·5 claims
- 0262US2025066440A1Methods of treatment using modified fgf-1 polypeptidesTREFOIL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0360US2021338777A1Modified fibroblast growth factors for the treatment of ocular disordersTREFOIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0457US2024024421A1Recombinant modified fibroblast growth factors and therapeutic uses thereofTREFOIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0536US2021009650A1Modified fibroblast growth factors and uses thereofTREFOIL THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0631US11479591B2Recombinant modified fibroblast growth factors and therapeutic uses thereofTREFOIL THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when TREFOIL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →